CYSTOP

Food supplement declared in France, declaration No 2017-5-1224, decision dated 30 May 2017

CYSTOP is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand: not provided
Food business operator placing the product on the market: LABORATOIRES BRYSSICA
Status: Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form: Gélule
Daily dose: Une gélule par jour
Directions for use: Une gélule par jour à avaler avec un grand verre d'eau.
Intended populations: Femme
Objectives stated by the manufacturer (these are not authorised claims): Système urinaire

Declaration 281226, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

À vérifier
The composition lists additive E171 (titanium dioxide), removed from the list of additives allowed in food, supplements included: since 7 August 2022, a supplement containing it can no longer be placed on the market in the Union. The declaration predates this removal: if the product is still sold, its formula must have changed; check the label.
Source: Regulation (EU) 2022/63: titanium dioxide (E171) removed from the food additives allowed in the EU, règlement (UE) 2022/63.

Declared composition

Plants

Plant	Part	Preparation	Per day
Calluna vulgaris (L.) Hull	Fleur	Extrait sec aqueux	250 mg
Vaccinium macrocarpon Aiton	Fruit	Extrait sec hydroalcoolique	240 mg

Additives

Hydroxypropyl Méthyl Cellulose, E171, E172, E470b, E551

List from the declaration, administrative decision dated 30 May 2017 (Compl'Alim, food supplement declarations (France)).

List recorded in 2017. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.